MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESOURCE REPOSITORY (MID-BRR)

微生物学和传染病生物资源库（MID-BRR）

• 批准号: 9326080
• 负责人: TIMOTHY T STEDMAN
• 金额: $ 2.59万
• 依托单位: AMERICAN TYPE CULTURE COLLECTION
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-06-30 至 2016-06-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9326080
• 关键词: Basic Science; Biological; Biological Preservation; Categories; Centers for Disease Control and Prevention (U.S.); Communicable Diseases; Communities; Contracts; Ebola virus; Emerging Communicable Diseases; Microbiology; National Institute of Allergy and Infectious Disease; Production; Reagent; Research; Resources; disorder prevention; pathogen; product development; repository; research and development

This contract provides unique and quality-assured infectious reagents and resources to the scientific community for use in basic research and product development. The scope of this contract includes the acquisition, authentication, production, preservation, storage, and distribution of research and reference reagents to the research community. These reagents span the 270 pathogens in the Division of Microbiology and Infectious Diseases portfolio, and include the National Institutes of Allergy and Infectious Disease (NIAID) Category A, B and C Priority Pathogens up to Biosafety Level 3 (BSL-3) and emerging infectious diseases, including those identified by the Centers for Disease Control and Prevention (CDC).

该合同为科学界提供了独特而质量的传染性试剂和资源，用于基础研究和产品开发。该合同的范围包括对研究界的研究和参考试剂的获取，身份验证，生产，保存，存储和分发。这些试剂跨越了微生物学和感染性疾病组合中的270种病原体，包括过敏和传染病（NIAID）类别A，B和C优先病原体的国家机构，直至生物安全3（BSL-3）（BSL-3）（BSL-3）（BSL-3）和新兴的感染性疾病，包括这些疾病的疾病，包括这些疾病的疾病和疾病（包括这些疾病）。